VAUGHAN, Ontario–( )–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Glaucoma Research Foundation (GRF), a national non-profit organization with the vision of curing glaucoma, today announced the U. S. launch of ‘ Screen, Protect, Cure , ’ a campaign designed to provide educational resources and raise awareness of glaucoma, a top cause of irreversible blindness, during Glaucoma Awareness Month. 1

We are proud in order to collaborate with Glaucoma Study Foundation to provide critical information about this serious eye disease and underline the negative toll it can have if left untreated, ” said Christina Ackermann, president, Ophthalmic Pharmaceuticals, Bausch + Lomb. “ Glaucoma can affect individuals associated with all ages and only half of those affected are aware they have got it, so it’s important that we share risk factors, how to get tested and what treatment options are available. Through ‘Screen, Protect, Cure, ’ we hope in order to help support patients in every step of their treatment journey. ” 1

During the particular month of January, Glaucoma Awareness Month, Bausch + Lomb plus GRF will share educational resources to educate individuals who may be at risk for glaucoma and empower them to take an informed and active role in their vision health. The campaign also features a fundraising challenge that will match every dollar raised up to $20, 000 in support of GRF research for the potential cure for glaucoma.

Glaucoma Consciousness Month provides a great opportunity in order to share information about this sight-threatening illness and remind people there are steps they can take to help preserve their vision, ” said Thomas M. Brunner, chief executive & CEO, GRF. “ Visiting an eye care provider on an annual basis plus paying attention to visual function are the best things someone can do to avoid the irreversible damage from glaucoma. Although there is currently no cure, our fight to prevent visible disability is ongoing, and we are usually grateful for the collaboration associated with organizations, such as Bausch + Lomb, who share this particular commitment with us. ”

People interested in participating in the particular fundraising problem or testing their knowledge about glaucoma can get an interactive quiz plus learn more at glaucoma. org/screen-protect-cure .

About Glaucoma

Glaucoma is a complex, progressive disease that occurs when excessive eye pressure or other causes lead to harm of the optic nerve. The optic nerve will be responsible with regard to the communication of information between the attention and brain. Damage in order to the optic nerve can lead to severe eyesight loss, and in the particular worst case, blindness. As one of the leading causes of preventable blindness, glaucoma affects about three million individuals in the United States, but if caught early, it is possible to help slow and potentially prevent vision loss. 1, 2

About Glaucoma Research Basis

Founded within 1978, GRF is focused on its mission in order to cure glaucoma through innovative research, leading the industry as a nonprofit organization. Building teams of collaborating researchers and scientists over the years, all sharing the common goal of finding a cure – GRF is committed to raising awareness, spreading the word and encouraging others to achieve this shared goal. For more information visit, , and follow them upon Facebook , Instagram , LinkedIn , and Twitter .

About Bausch + Lomb

Bausch + Lomb is usually dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment associated with birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care items, eye care products, ophthalmic pharmaceuticals, over-the-counter products plus ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing plus commercial footprint with a lot more than 12, 000 employees and the presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario along with corporate offices in Bridgewater, New Jersey. For more info, visit and connect with us on Tweets , LinkedIn , Facebook and Instagram .

Forward-looking Statements

This news release may contain forward-looking statements, which may generally be identified by the use of the words “anticipates, ” “hopes, ” “expects, ” “intends, ” “plans, ” “should, ” “could, ” “would, ” “may, ” “believes, ” “estimates, ” “potential, ” “target, ” or “continue” and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results in order to differ materially from all those described within the forward-looking statements. These types of risks plus uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb’s filings with the Oughout. S. Securities and Exchange Commission and the Canadian Investments Administrators, which factors are usually incorporated herein by reference. They furthermore include, but are not limited to, risks and uncertainties caused simply by or relating to the particular evolving COVID-19 pandemic, as well as the fear associated with that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, plus which might have a material adverse impact on Bausch + Lomb, including but not limited in order to its project development timelines, launches and costs (which may increase). Readers are usually cautioned not to place undue reliance on any of these forward-looking claims. These forward-looking statements speak only as of the date hereof. Bausch + Lomb undertakes no obligation to update some of these forward-looking statements to reflect events or circumstances after the date of this news release or to reveal actual outcomes, unless required by law.


  1. U. S. Centers for Disease Control plus Prevention. Retrieved from . Reviewed on Nov. 8, 2022.
  2. Mayo Clinic. Retrieved from . Reviewed on Nov. 8, 2022.

®/TM are trademarks associated with Bausch & Lomb Incorporated or the affiliates.

All other product/brand names and/or logos are usually trademarks of the respective owners.

© 2023 Bausch & Lomb Integrated or its affiliates.

UBL. 0055. USA. 22

Leave a Reply

Your email address will not be published. Required fields are marked *